Chemoinformaics analysis of 3-METHYLCYCLOPENTANONE
| Molecular Weight | 98.145 | nRot | 0 |
| Heavy Atom Molecular Weight | 88.065 | nRig | 6 |
| Exact Molecular Weight | 98.0732 | nRing | 1 |
| Solubility: LogS | -0.606 | nHRing | 0 |
| Solubility: LogP | 0.771 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 17 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 17.4899 |
| nHD | 0 | BPOL | 10.9001 |
| QED | 0.447 |
| Synth | 2.739 |
| Natural Product Likeliness | 1.444 |
| NR-PPAR-gamma | 0.08 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.003 |
| HIA | 0.009 |
| CACO-2 | -4.357 |
| MDCK | 0.0000337 |
| BBB | 0.994 |
| PPB | 0.248323 |
| VDSS | 0.875 |
| FU | 0.706943 |
| CYP1A2-inh | 0.19 |
| CYP1A2-sub | 0.77 |
| CYP2c19-inh | 0.06 |
| CYP2c19-sub | 0.693 |
| CYP2c9-inh | 0.021 |
| CYP2c9-sub | 0.864 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.816 |
| CYP3a4-inh | 0.008 |
| CYP3a4-sub | 0.186 |
| CL | 10.36 |
| T12 | 0.851 |
| hERG | 0.012 |
| Ames | 0.148 |
| ROA | 0.039 |
| SkinSen | 0.264 |
| Carcinogencity | 0.095 |
| EI | 0.985 |
| Respiratory | 0.147 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.950276 |